Stock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit

Stock Track

2024-10-28

信達生物9.27%

Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.

According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.

The significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

no data

沒有相關數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1196287764"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196287764\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1196287764?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 17:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196287764","market":"hk","top_or_hot":-1,"title":"Stock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit","media":"Stock Track","content":"<p>Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.</p>\n\n<p>According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.</p>\n\n<p>The significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-10-28 17:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.</p>\n\n<p>According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.</p>\n\n<p>The significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信達生物","start_time":0,"source_url":"","article_id":"1196287764","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196287764","pubTimestamp":1730109284,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Innovent Biologics Inc.  plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01801":"信达生物"},"translate_title":"股票追踪信达生物因单位股份稀释而暴跌逾13%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1},"content_text":"Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.\nAccording to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.\nThe significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}

如果下載按鈕點擊無跳轉，請點擊右上角菜單選擇 “在瀏覽器打開”

立即諮詢
下載APP
掃碼下載APP